Huangyang Meng

752 citations
22 papers · 423 indexed · h-index 12
Topics
Ferroptosis and cancer prognosis (7 papers)Cancer-related molecular mechanisms research (7 papers)Ovarian cancer diagnosis and treatment (6 papers)
Partner nations
China

In The Last Decade

Huangyang Meng

20 papers receiving 421 citations

Peers

Huangyang Meng
Comparison fields: 5 of 42
  • Molecular Biology 306
  • Cancer Research 236
  • Pulmonary and Respiratory Medicine 129
  • Oncology 85
  • Immunology 39
Replace Jinxiao Liang with:
Jinxiao Liang China
Tabari M. Baker United States
Jayne Maidens Australia
Jodi A. McKenzie United States
Qiuyan Guo China
Qiyu Zhong China
Elisabeth Breit Germany
Valerie Heong Singapore
Xuehu Xu China
Rui-Ming Yan China
Huangyang Meng relative to Jinxiao Liang China Jinxiao Liang's profile →
Citations per field
00.5×5.0×
Jinxiao Liang · 1×
Citations per year

Countries citing papers authored by Huangyang Meng

Since Specialization
Citations

This map shows the geographic impact of Huangyang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huangyang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huangyang Meng more than expected).

Fields of papers citing papers by Huangyang Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huangyang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huangyang Meng. The network helps show where Huangyang Meng may publish in the future.

Co-authorship network of co-authors of Huangyang Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Huangyang Meng. A scholar is included among the top collaborators of Huangyang Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huangyang Meng. Huangyang Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 30
4 10
5 3
6 2
7 0
8 6
9 107
10 10
11 11
12 20
13 31
14 17
15 53
16 31
17 22
18 2
19 31
20 16

About Huangyang Meng

Huangyang Meng is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 22 papers that have together received 423 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). The work is most often cited by research in Cancer Research (236 citations), Molecular Biology (306 citations) and Obstetrics and Gynecology (32 citations). Huangyang Meng has collaborated with scholars based in China. Frequent co-authors include Jinhui Liu, Sipei Nie, Rui Sun, Yicong Wan, Siyue Li, Wenjun Cheng, Jing Yang, Wenjun Cheng, Lin Zhang and Yi Jiang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Death and Differentiation and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026